- Condition: Obesity
Intervention: Drug: Propofol, Fentanyl
Sponsors: Stanford University; Stanford University; National Institute of General Medical Sciences (NIGMS)
Recruiting - verified May 2012 - Conditions: Hyperhydrosis; Depression
Intervention: Drug: Glycopyrrolate
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified April 2012 - Condition: Pain
Interventions: Drug: fentanyl; Drug: fentanyl, sufentanil
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc
Recruiting - verified April 2012 - Condition: Advanced Solid Tumors, Excluding Breast Cancer
Interventions: Drug: caffeine; Drug: diclofenac; Drug: omeprazole; Drug: midazolam; Drug: TKI258
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Conditions: Shoulder Pain; Injury of Shoulder Region; Disorder of Shoulder; Disorder of Rotator Cuff; Disorder of Tendon of Biceps
Interventions: Drug: Dexamethasone; Drug: Bupivacaine
Sponsors: Lifespan; Lifespan; Tufts Medical Center; United States Naval Medical Center, Portsmouth
Not yet recruiting - verified March 2012 - Condition: General Anesthesia
Intervention: Drug: propofol
Sponsors: Ethicon Endo-Surgery; Ethicon Endo-Surgery
Recruiting - verified March 2012 - Conditions: Pain, Postoperative; Chronic Pain
Interventions: Drug: Methadone; Drug: Fentanyl
Sponsors: NorthShore University HealthSystem Research Institute; NorthShore University HealthSystem Research Institute
Recruiting - verified February 2012 - Condition: Healthy Volunteers
Interventions: Drug: Midazolam; Drug: vandetanib
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Condition: Post-Operative Pain
Interventions: Drug: Sufentanil NanoTab PCA System/15 mcg; Drug: morphine IV PCA
Sponsors: AcelRx Pharmaceuticals, Inc.; AcelRx Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Condition: Post-Operative Pain
Interventions: Drug: Sufentanil NanoTab PCA System/15 mcg; Drug: Placebo Sufentanil NanoTab PCA System
Sponsors: AcelRx Pharmaceuticals, Inc.; AcelRx Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Conditions: Abscess; Pain
Interventions: Drug: Intranasal Fentanyl; Drug: Intravenous Morphine
Sponsors: Columbia University; Columbia University
Recruiting - verified March 2012 - Condition: Malignant Neoplasm
Interventions: Drug: placebo administration; Drug: EMLA; Drug: propofol; Drug: fentanyl citrate
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Ultrasound; CT Scans; MRIs
Interventions: Drug: Dexmedetomidine; Drug: Midazolam; Drug: Fentanyl
Sponsors: Hospira, Inc.; Hospira, Inc.
Recruiting - verified April 2012 - Conditions: Advanced Cancers; Dyspnea
Interventions: Drug: Fentanyl; Other: Placebo; Other: Walking Tests; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Condition: Suicidal Ideation
Interventions: Drug: Ketamine; Drug: Midazolam
Sponsors: Mount Sinai School of Medicine; James Murrough
Recruiting - verified January 2012 - Condition: Anesthesia
Interventions: Drug: Midazolam; Drug: Fentanyl; Drug: Morphine
Sponsors: Hospira, Inc.; Hospira, Inc.
Recruiting - verified April 2012 - Condition: Solid Tumors
Interventions: Drug: tivantinib; Drug: omeprazole; Drug: s-warfarin; Drug: caffeine; Dietary Supplement: vitamin K; Drug: digoxin; Drug: midazolam
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; Medpace, Inc.
Recruiting - verified January 2012 - Condition: Agitation
Interventions: Drug: Haloperidol; Drug: Midazolam
Sponsors: Catholic Health East; Catholic Health East
Recruiting - verified December 2011 - Conditions: Neonatal Neurobehavior; Breastfeeding Outcomes
Interventions: Drug: Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour 0.25% bupivacaine and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine/ epinephrine 1:600,000;infusion 10mL/hour 0.25% bupivacaine, 2 mcg/mL fentanyl, and epinephrine 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 10mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 2.5 mcg/mL fentanyl, and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 5 mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 3.5 mcg/mL fentanyl, and epi 1:800,000; Drug: No epidural fentanyl or bupivacaine
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Not yet recruiting - verified April 2012 - Conditions: Maternal Anaesthesia and Analgesia Affecting Fetus or Newborn; Breast Feeding; Fentanyl; Bupivacaine; Nalbuphine
Intervention:
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Recruiting - verified February 2012 - Conditions: Colon Cancer; Rectal Cancer; Colonic Diverticulosis
Interventions: Drug: Fentanyl; Drug: Propofol; Drug: Midazolam
Sponsors: Saint Joseph Mercy Health System; Saint Joseph Mercy Health System
Recruiting - verified December 2011 - Condition: Surgical Procedures, Elective
Interventions: Drug: Sugammadex; Drug: Neostigmine; Drug: Glycopyrrolate
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Conditions: Anemia, Sickle Cell; Pain
Interventions: Drug: Fentanyl Citrate; Drug: Normal Saline
Sponsors: Montefiore Medical Center; hnin khine
Recruiting - verified April 2012 - Condition: Cocaine Dependence
Interventions: Drug: levodopa carbidopa and entacapone (LCE); Drug: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Not yet recruiting - verified December 2011 - Condition: Healthy Male Volunteer
Interventions: Drug: JNJ-38518168 (30 mg); Drug: JNJ-38518168 (10 mg); Drug: JNJ-38518168 (3 mg); Drug: Placebo; Drug: Midazolam and JNJ-38518168
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified April 2012 - Condition: Healthy Volunteer
Interventions: Drug: RO4917838; Drug: diazepam; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Epilepsy
Intervention: Drug: Diazepam
Sponsors: Neuronex, Inc.; Neuronex, Inc.
Recruiting - verified November 2011 - Condition: Cholinergic Function
Interventions: Drug: Scopolamine; Drug: Placebo; Drug: Donepezil
Sponsors: Hebrew Rehabilitation Center, Boston; Hebrew Rehabilitation Center, Boston
Recruiting - verified March 2012 - Condition: Obsessive Compulsive Disorder
Interventions: Drug: Ketamine; Drug: Midazolam
Sponsors: Goodman, Wayne, M.D.; Goodman, Wayne, M.D.
Not yet recruiting - verified June 2011 - Condition: Intubation; Difficult
Intervention: Drug: Midazolam
Sponsors: University of Vermont; University of Vermont
Recruiting - verified May 2011 - Condition: Pain
Interventions: Drug: Preservative free morphine; Drug: Fentanyl
Sponsors: Goodman, Evan, M.D.; Goodman, Evan, M.D.
Recruiting - verified May 2011 - Condition: Pain
Interventions: Drug: Fentanyl; Drug: Fentanyl
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified April 2012 - Condition: Epilepsy
Intervention: Drug: intranasal midazolam hydrochloride
Sponsors: Columbia University; Columbia University
Recruiting - verified January 2012 - Condition: Pain
Interventions: Drug: Fentanyl; Drug: Fentanyl; Drug: Oxycodone/acetaminophen; Drug: oxycodone/acetaminophen
Sponsors: University of Oklahoma; Stephen Thomas; University of Oklahoma
Recruiting - verified February 2012 - Condition: Female Patients With High Tone Pelvic Floor Dysfunction
Interventions: Drug: Vaginal Diazepam Suppository; Drug: Placebo Suppository
Sponsors: TriHealth Inc.; TriHealth Inc.
Recruiting - verified September 2011 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dextromethorphan hydrobromide; Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097; Drug: ketoconazole; Drug: midazolam hydrochloride; Drug: omeprazole; Drug: rifampin; Drug: tolbutamide
Sponsors: National Cancer Institute (NCI); University of Wisconsin, Madison; National Cancer Institute (NCI)
Recruiting - verified July 2011 - Conditions: Pro-inflammatory Activity; Immunologic Activity Alteration [PE]
Interventions: Drug: Fentanyl; Other: Cold pressor test; Other: Fentanyl plus cold pressor test
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified February 2012 - Condition: Primary Headaches (Includes Migraines, Tension, Cluster Headaches)
Interventions: Drug: Droperidol; Drug: Metoclopramide; Drug: Diphenhydramine
Sponsors: University of Iowa; University of Iowa
Recruiting - verified July 2011 - Condition: Post Operative Pain
Intervention: Drug: oxymorphone HCl
Sponsors: Endo Pharmaceuticals; Endo Pharmaceuticals
Recruiting - verified November 2011 - Condition: Acute Traumatic Pain in Aeromedical Patients
Interventions: Drug: Ketamine; Drug: Fentanyl
Sponsors: University of Utah; University of Utah
Not yet recruiting - verified July 2011 - Condition: Endothelial Dysfunction
Interventions: Drug: Trimethaphan; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified April 2012 - Condition: Depression
Intervention: Drug: Scopolamine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Hepatitis C
Interventions: Drug: Midazolam; Drug: BMS-791325
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified February 2012 - Condition: Cocaine Dependence
Interventions: Drug: TA-CD Vaccination; Other: Placebo Injection
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs Cooperative Studies Program; VA Maryland Health Care System; Columbia University; VA New York Harbor Healthcare System; University of Pennsylvania; Johns Hopkins University; University of Cincinnati; Celtic Pharma Development Services
Recruiting - verified September 2011 - Condition: Amblyopia
Interventions: Drug: Atropine; Device: Plano lens; Drug: Atropine
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Henry Ford Health System; Henry Ford Health System
Recruiting - verified May 2010 - Condition: Marijuana Abuse
Intervention: Drug: bupropion, diazepam, dronabinol, ramelteon (Investigational Drug)
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2009 - Conditions: Stress Disorders, Post-Traumatic; PTSD; Depression; Anxiety Disorder
Interventions: Drug: Midazolam; Drug: Ketamine
Sponsors: Mount Sinai School of Medicine; Dennis Charney; Department of Defense
Recruiting - verified March 2012 - Condition: Status Epilepticus
Intervention: Drug: lorazepam or diazepam
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Conditions: Minor Surgical Procedures With Monitored Anesthesia Care.; Driving Performance After Minor Ambulatory Surgery.
Interventions: Other: Control; Drug: Midazolam; Drug: Sufentanil; Drug: Propofol
Sponsors: Rush University Medical Center; Rush University Medical Center
Recruiting - verified April 2012 - Condition: Obesity
Interventions: Drug: Trimethaphan L-NMMA Insulin clamp; Drug: Saline, Insulin clamp
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Chronic Fatigue Syndrome; Orthostatic Intolerance; Postural Tachycardia Syndrome
Interventions: Other: Autonomic Function Testing; Other: Saline infusions; Drug: L-NMMA trimethaphan; Drug: methyldopa
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Unipolar Depression; Bipolar Depression
Intervention: Drug: Scopolamine
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Pain; Perioperative/Postoperative Complications; Sarcoma
Interventions: Drug: fentanyl citrate; Drug: hydromorphone hydrochloride; Drug: ropivacaine hydrochloride
Sponsors: National Cancer Institute (NCI); University of California, San Francisco; National Cancer Institute (NCI)
Recruiting - verified September 2007 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: OBESITY; HYPERTENSION; PURE AUTONOMIC FAILURE; SHY-DRAGER SYNDROME
Interventions: Drug: Trimethaphan; Drug: Trimethaphan; Drug: Pseudoephedrine
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Mood Disorders; Healthy; Unipolar Depression; Bipolar Depression
Intervention: Drug: Transderm Scopolamine
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified July 2011
 |
Adjuvants Anesthesia Clinical Trials |
